We are live on
!
Find out more
Nuvation Bio
NUVB
NUVB
231 hedge funds and large institutions have $947M invested in Nuvation Bio in 2026 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 90 increasing their positions, 58 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
55% more repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 58
45% more call options, than puts
Call options by funds: $5.27M | Put options by funds: $3.64M
27% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 37
4% more funds holding
Funds holding: 223 → 231 (+8)
1.92% more ownership
Funds ownership: 61.7% → 63.62% (+1.9%)
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
50% less capital invested
Capital invested by funds: $1.89B → $947M (-$948M)
Holders
231
Holders Change
+8
Holders Change %
+3.59%
% of All Funds
2.84%
Holding in Top 10
5
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-44.44%
% of All Funds
0.06%
New
47
Increased
90
Reduced
58
Closed
37
Calls
$5.27M
Puts
$3.64M
Net Calls
+$1.63M
Net Calls Change
-$24.5M
Top Buyers
| 1 |
DFO
Duquesne Family Office
New York
|
+$25.3M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$15.9M |
| 3 |
Two Sigma Investments
New York
|
+$10.9M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$10.8M |
| 5 |
AG
Algert Global
San Francisco,
California
|
+$8.64M |
